The future of diagnostics
is at hand
United as one, we are transforming the power of diagnostics into a healthier future for all. Quidel Corporation and Ortho Clinical Diagnostics are now QuidelOrtho.
In global pursuit of better health outcomes
We are driven to transform diagnostic data into answers, understanding and action for more people in more places every day.
For more information:
News & Events
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results